|
|
|
|
|
|
|
|
THE TOP NEWS IN MARIJUANA LAW REFORM |
|
Volume 27 • Issue 28 • July 18, 2024 |
|
Prenatal Cannabis Exposure Not Associated With Elevated Risk of Autism |
|
Investigators reported no link between cannabis exposure and ASD after controlling for relevant covariates, particularly tobacco consumption. |
|
|
|
Study: Consumers Report Improvements in Anxiety, Depression Following Cannabis Use |
|
Investigators concluded, "Results at the user level of analysis showed that the majority of users experienced positive relief outcomes." |
|
|
|
|
LATEST NEWS |
|
|
|
|
|
Rescheduling Comments Deadline is July 22 |
|
Don't miss your chance to submit public comment to the DEA on marijuana rescheduling. NORML's step-by-step submission guide and talking points will assist you in taking part in this once in a lifetime opportunity to shape federal cannabis policy. |
|
|
|
|
ACTION ALERTS |
|
|
|
|
|
Meta-Analysis: Cannabis-Induced Psychosis Rare in Those Without Pre-Existing Mental Health Conditions |
|
"[N]either young age of onset of cannabis use nor high-frequency use of cannabis or the preferred type of cannabis was associated with cannabis-associated psychotic symptoms." |
|
|
|
Survey: Patients Say Cannabis Effectively Treats Their Musculoskeletal Pain |
|
Over 90 percent of consumers said that cannabis was either "very," "somewhat," or "slightly" effective at managing their pain, improving their sleep, and reducing anxiety-related symptoms. |
|
|
|
|
NORML IN THE MEDIA |
|
|
|
|
|
|
|
|
